• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生评估的合理方法:最新进展

A rational approach to benign prostatic hyperplasia evaluation: recent advances.

作者信息

Bhargava Saurabh, Canda A Erdem, Chapple Christopher R

机构信息

Department of Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.

出版信息

Curr Opin Urol. 2004 Jan;14(1):1-6. doi: 10.1097/00042307-200401000-00001.

DOI:10.1097/00042307-200401000-00001
PMID:15091041
Abstract

PURPOSE OF REVIEW

In this article we aim to outline the recent advances in the evaluation of a patient with symptoms suggestive of benign prostatic hyperplasia. We define the role of the clinical evaluation and techniques that are evolving for the appropriate management of a patient with benign prostatic hyperplasia. Both non-invasive and invasive investigation techniques are reviewed.

RECENT FINDINGS

Initiating early and appropriate treatment is the primary aim of investigation for a patient with lower urinary tract symptoms. Both clinical history and examination and appropriate investigations are vital to establishing a diagnosis. Symptom scores, prostate specific antigen and prostate volume were found to closely relate in predicting the progression of benign prostatic hyperplasia and in recent years increased interest has centred on the progression of this disease principally related to the development of new pharmacotherapy. Despite these positive findings further research is needed to develop reliable tools to predict progression. Newer ultrasound techniques hold promise for the future. Conventional pressure flow studies have a defined role in excluding patients who are less likely to benefit from prostatic surgery by providing information on detrusor function; and non-invasive urodynamic techniques need further evaluation but appear to be promising.

SUMMARY

The minimal initial evaluation of a patient with benign prostatic hyperplasia should include a thorough history, digital rectal and neurological examinations, symptom scoring (including quality of life and sexual score) and measurement of serum prostate specific antigen. Other methods should be reserved for more complex situations. Attempts should be made at identifying those patients in whom the disease process is likely to progress.

摘要

综述目的

在本文中,我们旨在概述对有良性前列腺增生疑似症状患者进行评估的最新进展。我们明确临床评估的作用以及为恰当管理良性前列腺增生患者而不断发展的技术。对非侵入性和侵入性检查技术均进行了综述。

最新发现

对下尿路症状患者进行检查的主要目的是尽早开始并进行恰当治疗。临床病史、体格检查以及恰当的检查对于确诊至关重要。症状评分、前列腺特异性抗原和前列腺体积在预测良性前列腺增生进展方面密切相关,并且近年来人们对该疾病进展的兴趣主要集中在与新药物治疗开发相关的方面。尽管有这些积极发现,但仍需要进一步研究以开发可靠的预测进展的工具。更新的超声技术前景广阔。传统的压力流研究通过提供逼尿肌功能信息,在排除不太可能从前列腺手术中获益的患者方面具有明确作用;非侵入性尿动力学技术需要进一步评估,但似乎很有前景。

总结

对良性前列腺增生患者的最低限度初始评估应包括详尽的病史、直肠指检和神经学检查、症状评分(包括生活质量和性功能评分)以及血清前列腺特异性抗原测定。其他方法应留待更复杂的情况使用。应尝试识别那些疾病进程可能进展的患者。

相似文献

1
A rational approach to benign prostatic hyperplasia evaluation: recent advances.良性前列腺增生评估的合理方法:最新进展
Curr Opin Urol. 2004 Jan;14(1):1-6. doi: 10.1097/00042307-200401000-00001.
2
[New developments in the diagnosis of benign prostatic hyperplasia].[良性前列腺增生诊断的新进展]
Rev Med Chir Soc Med Nat Iasi. 2006 Jan-Mar;110(1):88-96.
3
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
4
Investigation of benign prostatic hyperplasia.良性前列腺增生的研究
Curr Opin Urol. 2003 Jan;13(1):17-22. doi: 10.1097/00042307-200301000-00004.
5
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.EAU 指南:非神经原性男性下尿路症状包括良性前列腺增生的评估。
Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19.
6
Benign prostatic hyperplasia: clinical manifestations and evaluation.良性前列腺增生:临床表现与评估
Tech Vasc Interv Radiol. 2012 Dec;15(4):265-9. doi: 10.1053/j.tvir.2012.09.007.
7
Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.膀胱内前列腺突出与阻力指数相结合有助于预测提示良性前列腺增生的下尿路症状患者的膀胱出口梗阻。
Int J Urol. 2016 Nov;23(11):929-933. doi: 10.1111/iju.13188. Epub 2016 Aug 21.
8
Prevention of benign prostatic hyperplasia disease.良性前列腺增生症的预防。
J Urol. 2006 Oct;176(4 Pt 1):1299-306. doi: 10.1016/j.juro.2006.06.022.
9
Can noninvasive evaluation of benign prostatic obstruction be optimized?良性前列腺梗阻的无创评估能否得到优化?
Curr Opin Urol. 2012 Jan;22(1):1-6. doi: 10.1097/MOU.0b013e32834d8e74.
10
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.每日一次他达拉非治疗临床良性前列腺增生症下尿路症状患者的尿动力学效果:一项随机、安慰剂对照的 12 周临床试验。
J Urol. 2010 Mar;183(3):1092-7. doi: 10.1016/j.juro.2009.11.014. Epub 2010 Jan 25.

引用本文的文献

1
Histomorphological effects of the oil extract of seed on benign prostatic hyperplasia induced by exogenous testosterone and estradiol in adult Wistar rats.种子油提取物对成年Wistar大鼠外源性睾酮和雌二醇诱导的良性前列腺增生的组织形态学影响。
Avicenna J Phytomed. 2019 Jan-Feb;9(1):21-33.
2
D-004 ameliorates phenylephrine-induced urodynamic changes and increased prostate and bladder oxidative stress in rats.D-004改善苯肾上腺素诱导的大鼠尿动力学变化,并减轻前列腺和膀胱氧化应激。
Transl Androl Urol. 2015 Aug;4(4):391-7. doi: 10.3978/j.issn.2223-4683.2014.03.05.
3
Effects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study.
古巴王棕(大王椰子)果实的脂质提取物D - 004或锯叶棕(沙巴棕)的脂质甾醇提取物对雄性大鼠性活动的影响:一项对照实验研究。
Curr Ther Res Clin Exp. 2008 Feb;69(1):65-74. doi: 10.1016/j.curtheres.2008.01.002.
4
Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.在大鼠中,将添加到王棕果实脂质提取物D - 004中的(³H)-油酸单剂量给药后的血浆水平、组织分布及放射性排泄情况。
Curr Ther Res Clin Exp. 2006 Nov;67(6):406-19. doi: 10.1016/j.curtheres.2006.12.005.
5
In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.古巴王棕(大王椰子,Roystonea regia)果实的脂质提取物D-004对前列腺甾体5α-还原酶活性的体外作用。
Curr Ther Res Clin Exp. 2006 Nov;67(6):396-405. doi: 10.1016/j.curtheres.2006.12.004.
6
Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.古巴王棕果脂质提取物D - 004对抑制大鼠模型中由睾酮或双氢睾酮诱导的前列腺增生的作用:一项随机对照研究。
Curr Ther Res Clin Exp. 2004 Nov;65(6):505-14. doi: 10.1016/j.curtheres.2005.01.001.
7
Antioxidant effects of D-004, a lipid extract from the Roystonea regia fruit, on the plasma of healthy men.王棕果实脂质提取物D-004对健康男性血浆的抗氧化作用。
Asian J Androl. 2009 May;11(3):385-92. doi: 10.1038/aja.2008.34. Epub 2009 Jan 26.